[1]尹萌辰,于文龙,于文青,等.脊柱转移瘤诊疗及其智能化的研究进展[J].中医正骨,2026,38(07):43-49.
 YIN Mengchen,YU Wenlong,YU Wenqing,et al.Advances in research on the diagnosis and treatment of spinal metastases and their intelligentization[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2026,38(07):43-49.
点击复制

脊柱转移瘤诊疗及其智能化的研究进展()

《中医正骨》[ISSN:1001-6015/CN:41-1162/R]

卷:
第38卷
期数:
2026年07期
页码:
43-49
栏目:
综述
出版日期:
2026-07-20

文章信息/Info

Title:
Advances in research on the diagnosis and treatment of spinal metastases and their intelligentization
作者:
尹萌辰1; 于文龙2; 于文青3; 陈定榜2; 黄权2; 杨兴海2; 王树强1
1.上海中医药大学附属岳阳中西医结合医院,上海 200437; 2.海军军医大学第二附属医院,上海 200003; 3.德州市第二人民医院,山东 德州 253004
Author(s):
YIN Mengchen; YU Wenlong; YU Wenqing; CHEN Dingbang; HUANG Quan; YANG Xinghai; WANG Shuqiang
关键词:
脊椎肿瘤;  肿瘤转移;  外科手术;  围手术期医护;  预后;  人工智能;  综述
摘要:
脊柱转移瘤是恶性肿瘤晚期最常见的骨转移类型之一,可导致椎体病理性骨折、脊柱失稳、脊髓损伤等,严重影响患者的生存质量。随着多学科协作理念的深化与医疗技术的持续进步,脊柱转移瘤的诊疗体系逐步完善。人工智能的引入,也逐步推动脊柱转移瘤的诊疗向智能化转变。本文从脊柱转移瘤的诊疗决策与预后评估、治疗策略及人工智能在脊柱转移瘤诊疗中的应用3个方面,对脊柱转移瘤的诊疗及其智能化的研究进展进行了综述,为脊柱转移瘤的临床诊疗提供了参考。

参考文献/References:

[1] YIN M,SUN Z,DING X,et al.Cross-cultural adaptation and validation of simplified Chinese version of the Spine Oncology Study Group Outcomes Questionnaire(SOSGOQ)2.0 with its assessment in clinical setting[J].Spine J,2022,22(12):2024-2032.
[2] 于文龙,丁兴,王韬,等.脊柱转移瘤治疗决策系统的研究进展[J].脊柱外科杂志,2023,21(5):345-349.
[3] 尹萌辰,刘韩森,李林,等.脊柱转移瘤预后评分系统的研究进展[J].中国脊柱脊髓杂志,2023,33(4):344-352.
[4] 尹萌辰,于文龙,李林,等.脊柱转移瘤患者健康相关生活质量测量工具的研究进展[J].中华骨科杂志,2023,43(16):1115-1122.
[5] QIAO L,DING X,HE S,et al.Measurement properties of health-related quality of life measures for people living with metastatic disease of the spine:a systematic review[J].Int J Surg,2024,110(1):419-430.
[6] QIAO L,CHEN D,ZHANG F,et al.Assessing cross-cultural adaptation of the Spine Oncology Study Group Outcomes Questionnaire 2.0:a methodological systematic review regard to Consensus-Based Standards for the Selection of Health Measurement Instruments guideline[J].Global Spine J,2024,14(4):1347-1355.
[7] DEMURA S,KATO S,SHINMURA K,et al.Perioperative complications of total en bloc spondylectomy for spinal tumours[J].Bone Joint J,2021,103-B(5):976-983.
[8] YU W,CHEN D,DING X,et al.A critical appraisal of clinical practice guidelines on surgical treatments for spinal metastasis[J].Eur Spine J,2024,33(5):1868-1898.
[9] FANG G,YU W,CHEN D,et al.Development of a core outcome set of clinical research on the integration of traditional Chinese and Western medicine for spinal metastases:a study protocol[J].BMJ Open,2024,14(9):e083315.
[10] LI F,YU W,ZHOU H,et al.Construction and development of an enhanced recovery after surgery program for the surgical management of patients with spinal metastasis:a modified Delphi study[J].Orthop Surg,2025,17(3):939-952.
[11] 《脊柱转移瘤气虚血瘀证诊断标准》项目专家组.基于德尔菲法构建《脊柱转移瘤气虚血瘀证诊断标准》专家共识[J].中医正骨,2025,37(3):1-4.
[12] TOKUHASHI Y,MATSUZAKI H,TORIYAMA S,et al.Scoring system for the preoperative evaluation of metastatic spine tumor prognosis[J].Spine(Phila Pa 1976),1990,15(11):1110-1113.
[13] LAUFER I,RUBIN D G,LIS E,et al.The NOMS framework:approach to the treatment of spinal metastatic tumors[J].Oncologist,2013,18(6):744-751.
[14] BILSKY M H,LAUFER I,FOURNEY D R,et al.Reliability analysis of the epidural spinal cord compression scale[J].J Neurosurg Spine,2010,13(3):324-328.
[15] CAO X,JIANG W,ZHANG B,et al.A new treatment strategy for spinal metastasis:the “systemic conditions,effectiveness of systemic treatment,neurology,and oncology” decision framework system[J].Neurosurgery,2024,94(3):584-596.
[16] PENNINGTON Z,AHMED A K,COTTRILL E,et al.Intra- and interobserver reliability of the Spinal Instability Neoplastic Score system for instability in spine metastases:a systematic review and meta-analysis[J].Ann Transl Med,2019,7(10):218.
[17] MEZEI T,HORVATH A,POLLNER P,et al.Research on the predicting power of the revised Tokuhashi system:how much time can surgery give to patients with short life expectancy?[J].Int J Clin Oncol,2020,25(4):755-764.
[18] 弓伊宁,胡锦心,韦峰,等.Tomita评分及改良Tokuhashi评分对脊柱转移瘤手术患者生存期预测的准确性[J].中国脊柱脊髓杂志,2021,31(2):97-102.
[19] SCHOENFELD A J,FERRONE M L,BLUCHER J A,et al.Prospective comparison of the accuracy of the New England Spinal Metastasis Score to legacy scoring systems in prognosticating outcomes following treatment of spinal metas-tases[J].Spine J,2022,22(1):39-48.
[20] SHI D D,CHEN Y H,LAM T C,et al.Assessing the utility of a prognostication model to predict 1-year mortality in patients undergoing radiation therapy for spinal metastases[J].Spine J,2018,18(6):935-940.
[21] DE LA GARZA RAMOS R,NAIDU I,CHOI J H,et al.Comparison of three predictive scoring systems for morbidity in oncological spine surgery[J].J Clin Neurosci,2021,94:13-17.
[22] CHOI D,PAVLOU M,OMAR R,et al.A novel risk calculator to predict outcome after surgery for symptomatic spinal metastases:use of a large prospective patient database to personalise surgical management[J].Eur J Cancer,2019,107:28-36.
[23] TOMITA K,TORIBATAKE Y,KAWAHARA N,et al.Total en bloc spondylectomy and circumspinal decompression for solitary spinal metastasis[J].Paraplegia,1994,32(1):36-46.
[24] KATO S,DEMURA S,SHINMURA K,et al.Surgical metastasectomy in the spine:a review article[J].Oncologist,2021,26(10):e1833-e1843.
[25] KATO S,MURAKAMI H,DEMURA S,et al.More than 10-year follow-up after total en bloc spondylectomy for spinal tumors[J].Ann Surg Oncol,2014,21(4):1330-1336.
[26] ALMEKKAWI A K,BHOJANE A,EDELBACH B,et al.En bloc spondylectomy versus separation surgery for spinal metastases:a systematic review and meta-analysis[J].World Neurosurg,2025,200:124129.
[27] REDMOND K J,LO S S,SOLTYS S G,et al.Consensus guidelines for postoperative stereotactic body radiation therapy for spinal metastases:results of an international survey[J].J Neurosurg Spine,2017,26(3):299-306.
[28] PATCHELL R A,TIBBS P A,REGINE W F,et al.Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer:a randomised trial[J].Lancet,2005,366(9486):643-648.
[29] GERSZTEN P C,MENDEL E,YAMADA Y.Radiotherapy and radiosurgery for metastatic spine disease:what are the options,indications,and outcomes?[J].Spine(Phila Pa 1976),2009,34(22 Suppl):S78-S92.
[30] CHAKRAVARTHY V B,SCHACHNER B,AMIN A G,et al.The impact of targetable mutations on clinical outcomes of metastatic epidural spinal cord compression in patients with non-small-cell lung cancer treated with hybrid therapy(surgery followed by stereotactic body radiation therapy)[J].Neurosurgery,2023,92(3):557-564.
[31] HUSSAIN I,GOLDBERG J L,CARNEVALE J A,et al.Hybrid therapy(surgery and radiosurgery)for the treatment of renal cell carcinoma spinal metastases[J].Neurosurgery,2022,90(2):199-206.
[32] MYREHAUG S,SAHGAL A,HAYASHI M,et al.Reirradiation spine stereotactic body radiation therapy for spinal metastases:systematic review[J].J Neurosurg Spine,2017,27(4):428-435.
[33] LAUFER I,IORGULESCU J B,CHAPMAN T,et al.Local disease control for spinal metastases following “separation surgery” and adjuvant hypofractionated or high-dose single-fraction stereotactic radiosurgery[J].J Neurosurg Spine,2013,18(3):207-214.
[34] ALCORN S,CORTÉS Á A,BRADFIELD L,et al.External beam radiation therapy for palliation of symptomatic bone metastases:an ASTRO clinical practice guideline[J].Pract Radiat Oncol,2024,14(5):377-397.
[35] BERENSON J,PFLUGMACHER R,JARZEM P,et al.Balloon kyphoplasty versus non-surgical fracture management for treatment of painful vertebral body compression fractures in patients with cancer:a multicentre,randomised controlled trial[J].Lancet Oncol,2011,12(3):225-235.
[36] FORESI B,SHAH A,MEADE S,et al.Tumor markers in non-small cell lung cancer spine metastasis:an assessment of prognosis and overall survival[J].Eur Spine J,2024,33:4346-4352.
[37] HU J,ZHU J,WANG X,et al.Finite element validation and short-term clinical outcomes of robot-assisted percutaneous microwave ablation plus cement augmentation and sacroiliac screw fixation for upper sacral(S1-S2)metastases[J/OL].Eur Spine J,2026[2025-03-15].https://pubmed.ncbi.nlm.nih.gov/41746345/.
[38] KIM P,KIM S W.Bone cement-augmented percutaneous screw fixation for malignant spinal metastases:is it feasible?[J].J Korean Neurosurg Soc,2017,60(2):189-194.
[39] ZHANG Y,FANG X,LUO L,et al.Clinical analysis of microwave ablation combined with decompression and pedicle screw fixation in the treatment of spinal metastases[J].Orthop Surg,2024,16(6):1292-1299.
[40] RAMALINGAM S S,VANSTEENKISTE J,PLANCHARD D,et al.Overall survival with osimertinib in untreated,EGFR-mutated advanced NSCLC[J].N Engl J Med,2020,382:41-50.
[41] FOMCHENKO E I,BAYLEY J C,ALVAREZ-BRECKENRIDGE C,et al.Spinal metastases and the evolving role of molecular targeted therapy,chemotherapy,and immunotherapy[J].Neurospine,2022,19(4):978-993.
[42] MODI S,JACOT W,YAMASHITA T,et al.Trastuzumab deruxtecan in previously treated HER2-low advanced breast cancer[J].N Engl J Med,2022,387(1):9-20.
[43] GONG Y,WANG C,LIU H,et al.Only Tumors angiographically identified as hypervascular exhibit lower intraoperative blood loss upon selective preoperative embolization of spinal metastases:systematic review and meta-analysis[J].Front Oncol,2021,10:597476.
[44] WU C,LEE C Y,HUANG T J,et al.Cement-augmented pedicle screw insertion assisted by spinal robotic systems for widespread spinal metastases[J].J Robot Surg,2019,13(4):595-598.
[45] CLARENÇON F,MOREAU P E,CORTESE J,et al.Onyx injection by direct puncture for presurgical embolization of a C2 hypervascular metastasis from a thyroid cancer[J].J Neurointerv Surg,2022,14(1):neurintsurg-2020-017180.
[46] RAJE N,TERPOS E,WILLENBACHER W,et al.Denosu-mab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma:an international,double-blind,double-dummy,randomised,controlled,phase 3 study[J].Lancet Oncol,2018,19(3):370-381.
[47] WIDYADHARMA I P E,TERTIA C,VANIA A,et al.The effect of denosumab vs.zoledronic acid in preventing skeletal-related events,including pain-related bone metastasis:a systematic review[J].Postep Psychiatr Neurol,2024,33(3):172-177.
[48] KARHADE A V,THIO Q,OGINK P T,et al.Development of machine learning algorithms for prediction of 30-day mortality after surgery for spinal metastasis[J].Neurosurgery,2019,85(1):E83-E91.
[49] LIU B,JIN Y,FENG S,et al.Benign vs malignant vertebral compression fractures with MRI:a comparison between automatic deep learning network and radiologist's assessment[J].Eur Radiol,2023,33(7):5060-5068.
[50] ER H,TÖREN M,ASAN B,et al.Deep learning-based differentiation of vertebral body lesions on magnetic resonance imaging[J].Diagnostics(Basel),2025,15(15):1862.
[51] CHEN L,HOU G,ZHANG K,et al.Percutaneous CT-guided microwave ablation combined with vertebral augmentation for treatment of painful spinal metastases[J].AJNR Am J Neuroradiol,2022,43(3):501-506.
[52] PUSCEDDU C,MARSICO S,DERUDAS D,et al.Percutaneous CT-guided microwave ablation combined with pedicle screw fixation followed by vertebroplasty(MASFVA):initial experience of a minimally invasive treatment of vertebral metastases with extension to the vertebral pedicle[J].Curr Oncol,2023,30(2):1663-1672.
[53] ZUO T,HOU M,DU Z,et al.Clinical benefits of CT-guided microwave ablation combined with percutaneous vertebroplasty for spinal metastases:local tumor control and a multivariate analysis of bone cement leakage[J].Eur J Radiol,2025,185:112017.
[54] RUAN Q Z,SARRAFPOOR S,HASOON J,et al.Comparison of clinical outcomes between fluoroscopic and computer tomographic guidance in concurrent use of radiofrequency ablation and vertebral augmentation in spinal metastases:a scoping review[J].Diagnostics(Basel),2025,15(12):1463.
[55] SHIBER M,KIMCHI G,KNOLLER N,et al.The evolution of minimally invasive spine tumor resection and stabilization:from K-wires to navigated one-step screws[J].J Clin Med,2023,12(2):536.

相似文献/References:

[1]谢炜星,万超,晋大祥,等.经皮椎体强化术治疗脊柱溶骨性肿瘤[J].中医正骨,2015,27(09):50.
[2]朱丽英,胡春艳,孟苗,等.唑来膦酸静脉滴注联合华蟾素胶囊口服治疗转移性骨肿瘤[J].中医正骨,2017,29(07):55.
[3]李先玉.骶尾部脊索瘤与骨巨细胞瘤的MRI和CT影像特点比较[J].中医正骨,2018,30(05):28.
[4]张豪伟,刘帅,郭阿雷,等.Disc-FX系统射频消融联合经皮椎体成形术 治疗胸腰椎转移瘤[J].中医正骨,2018,30(09):75.
[5]刘艳,石丽红,谢新立,等.18F-FDG PET/CT在未知原发灶肿瘤骨转移诊断中的价值[J].中医正骨,2020,32(09):39.
[6]陈洪安,张银刚.后路椎板切除减压椎弓根钉棒系统内固定联合椎体成形术治疗溶骨性胸腰椎椎体转移瘤[J].中医正骨,2017,29(06):67.

备注/Memo

备注/Memo:
基金项目:中华中医药学会研究与评价课题(中药专项)资助项目(CACMREZZ2025-A-08); 2025年度上海市科学技术委员会关键技术研发计划“医学创新研究”项目(25Y12800904); 岳阳医院优势病种院级IIT项目(yyiit006)
通信作者:王树强 E-mail:misspinal@163.com
(收稿日期:2025-04-20 本文编辑:杨雅)
更新日期/Last Update: 2026-07-20